InsidersTradesSigma
Follow the Sun Pharmaceutical Industries Limited stock price and the full insider trade history of the company, a listed issuer based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Sun Pharmaceutical Industries Limited has recorded 141 public disclosures. Market capitalisation: €4,801.3bn. The latest transaction was filed on 29 August 2023 (Pledge). Among the most active insiders: Sailesh T. Desai. The full history is accessible without an account.
141
Insider Decl.
n/a
Thresholds
€119,499
1 ops.
Buy Volume
€8m
60 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sun Pharmaceutical Industries Limited Buy (bullish), based on 34 analysts. Average price target: ₹2,055.00.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,096 of 28,835 companies
60.7
score / 100
Value37
Quality84
FCF yld1.8%
Earn yld2.4%
EV/EBITDA26.4x
ROE15%
Gross mgn77%
Net mgn20%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 August 2023
Declarations141 total
●
2,020,000 shares@ ₹1,117.0010.0% of flowEquity SharesSEBI:e48bbeebd901a39932ce31b70784822d0959ba62
●
1,000,000 shares@ ₹937.454.1% of flowEquity SharesSEBI:6ce6db8ce10986f510f2b0d84e780c37f0b7f388
5,990,000 shares@ ₹983.9549.4% of flowEquity SharesSEBI:a08d57b2c3ba5b064eced38d727e591f9d0d2d7c
●
1,650,000 shares@ ₹961.207.1% of flowEquity SharesSEBI:ea9c4f910f945be15c87b1a97161613827f49309
4,000 shares@ ₹965.74250.4% of flowEquity SharesSEBI:fad4f481d41f11900c3b62f2db3b3e7908184dfe
119,837 shares@ ₹965.250.1% of flowEquity SharesSEBI:230fd8dfeb94a115417ed98f1fed1c732df3c9ac
●
1,160,000 shares@ ₹966.905.1% of flowEquity SharesSEBI:832030c66856f50f7c20af1b8f8bd06f34e624eb
●
8,101,000 shares@ ₹959.3035.1% of flowEquity SharesSEBI:b083d9542efff0941334d9ab1952ba1bebbc8a50
●
1,190,000 shares@ ₹968.555.2% of flowEquity SharesSEBI:81767463f5e7686be6c10b977916874651c18edf
●
2,420,000 shares@ ₹968.5510.5% of flowEquity SharesSEBI:5ac4b7f432a28adc602ac20521291fbc68536738
15,000 shares@ ₹996.501.5% of flowEquity SharesSEBI:5cacc68cf39c5cefd00d2e82660f4347e63aaa7b
6,000,000 shares@ ₹1,023.5050.6% of flowEquity SharesSEBI:63fdc5d9bc19370682d90314c4439b918530916b
●
3,000,000 shares@ ₹1,000.0513.5% of flowEquity SharesSEBI:7d9da1beea46aad339f7fb4c1107f9af34b63a43
5,000 shares@ ₹1,028.13560.5% of flowEquity SharesSEBI:6c25ddcde9c4ec5ce0d0acbb80f9ec8774cd46c0
2,000 shares@ ₹1,021.5930.2% of flowEquity SharesSEBI:bd55a769896c7dcb46a6faa26d933505f2773c31
2,000 shares@ ₹1,025.000.2% of flowEquity SharesSEBI:bd51c3b0a178bece7923e37d8e2ea0ee9b253927
●
450,000 shares@ ₹1,005.602.0% of flowEquity SharesSEBI:f384a94676a9d72a889fd38cc6226f944dc67bfa
3,000 shares@ ₹1,030.00100.0% of flowEquity SharesSEBI:9dec2a7487387c557c27c945a29dca20c75544b1
2,000 shares@ ₹1,028.54100.0% of flowEquity SharesSEBI:090b898d26179145f4091c6d6e38244a6bec278b
●
60,000 shares@ ₹1,040.000.3% of flowEquity SharesSEBI:bd0696d7eaef7e2ee98e9f631f6eb61fe17f6653
●
1,479,000 shares@ ₹1,046.057.2% of flowEquity SharesSEBI:1a0bcce8a48b8c860a646517feb2678ef9b169e7
●
1,000 shares@ ₹1,055.0050.2% of flowEquity SharesSEBI:0a4615999fd5ea4ebf1cf188e25b9856000ba1fb
●
1,000 shares@ ₹1,049.0049.8% of flowEquity SharesSEBI:3c61bd685cc2ff92998f48631649fcf4d2c75318
6,000 shares@ ₹1,047.63330.7% of flowEquity SharesSEBI:8a8fcdc89951bfdfe627474161e99b60e5ce3d70
10,000 shares@ ₹1,030.45041.1% of flowEquity SharesSEBI:476ecaca0ad1fc87712ce8fa13efee2827352608
25 of 141 declarations
About Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited is an Indian pharmaceutical company that develops, manufactures, and markets generic and branded pharmaceuticals. It is one of the largest drug manufacturers in India and operates globally.